Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.

BACKGROUND AND AIMS There is an unexplained association between ulcerative colitis [UC] and primary sclerosing cholangitis [PSC], with the intestinal microbiota implicated as an important factor. The study aim was to compare the structure of the intestinal microbiota of patients with UC with and without PSC. METHODS UC patients with PSC [PSC-UC] and without PSC [UC] were identified from biobanks at Oslo University Hospital, Foothills Hospital Calgary and Mount Sinai Hospital Toronto. Microbial DNA was extracted from colonic tissue and sequencing performed of the V4 region of the 16S rRNA gene on Illumina MiSeq. Sequences were assigned to operational taxonomic units [OTUs] using Quantitative Insights Into Microbial Ecology [QIIME]. Microbial alpha diversity, beta diversity, and relative abundance were compared between PSC-UC and UC phenotypes. RESULTS In all, 31 PSC-UC patients and 56 UC patients were included. Principal coordinate analysis [PCoA] demonstrated that city of sample collection was the strongest determinant of taxonomic profile. In the Oslo cohort, Chao 1 index was modestly decreased in PSC-UC compared with UC [p = 0.04] but did not differ significantly in the Calgary cohort. No clustering by PSC phenotype was observed using beta diversity measures. For multiple microbial genera there were nominally significant differences between UC and PSC-UC, but results were not robust to false-discovery rate correction. CONCLUSIONS No strong PSC-specific microbial associations in UC patients consistent across different cohorts were identified. Recruitment centre had a strong effect on microbial composition. Future studies should include larger cohorts to increase power and the ability to control for confounding factors.

[1]  E. Zoetendal,et al.  The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. , 2015, Journal of Crohn's & colitis.

[2]  Rob Knight,et al.  Advancing the Microbiome Research Community , 2014, Cell.

[3]  M. Silverberg,et al.  Analyzing the Human Microbiome: A “How To” guide for Physicians , 2014, The American Journal of Gastroenterology.

[4]  C. Huttenhower,et al.  Inflammatory bowel disease as a model for translating the microbiome. , 2014, Immunity.

[5]  C. Huttenhower,et al.  Relating the metatranscriptome and metagenome of the human gut , 2014, Proceedings of the National Academy of Sciences.

[6]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[7]  J. Talwalkar,et al.  Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis , 2013, BioMed research international.

[8]  M. Icaza-Chávez,et al.  Microbiota intestinal en la salud y la enfermedad , 2013 .

[9]  Kai-Uwe Eckardt,et al.  Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.

[10]  Judy H. Cho,et al.  Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis , 2013, Nature Genetics.

[11]  Falk Hildebrand,et al.  Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice , 2013, Genome Biology.

[12]  B. Finlay,et al.  The gut microbiota: challenging immunology , 2011, Nature Reviews Immunology.

[13]  G. Kaplan,et al.  Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. , 2011, Hepatology.

[14]  K. Lindor,et al.  Treatment options for primary sclerosing cholangitis , 2010, Expert review of gastroenterology & hepatology.

[15]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[16]  C. Moreno,et al.  A consistent terminology for quantifying species diversity? , 2010, Oecologia.

[17]  G. Gores,et al.  Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.

[18]  G. Kaplan,et al.  The Burden of Large and Small Duct Primary Sclerosing Cholangitis in Adults and Children: A Population-Based Analysis , 2007, The American Journal of Gastroenterology.

[19]  R. Knight,et al.  Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities , 2007, Applied and Environmental Microbiology.

[20]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[21]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[22]  R. Groszmann,et al.  American association for the study of liver diseases , 1992 .

[23]  R. Clark,et al.  Biliary tract disease in rats with experimental small bowel bacterial overgrowth , 1991, Hepatology.

[24]  Robert C. Edgar,et al.  Search and clustering orders of magnitude faster than BLAST , 2010 .